Compound class:
Synthetic organic
Comment: CFT7455 is a monofunctional IKZF1/3 degrader that was developed by C4 Therapeutics for potential to treat relapsed/refractory multiple myeloma. It is orally bioactive.
|
|
Classification | |
Compound class | Synthetic organic |
Ligand families/groups | PROTACs, molecular glues and other degraders |
IUPAC Name |
(3S)-3-[6-[[4-(morpholin-4-ylmethyl)phenyl]methyl]-2-oxobenzo[cd]indol-1-yl]piperidine-2,6-dione |
Database Links | |
CAS Registry No. | 2504235-67-8 (source: PubChem) |
GtoPdb PubChem SID | 464244102 |
PubChem CID | 155207651 |
Search Google for chemical match using the InChIKey | MUKCJOOKCZSQNW-DEOSSOPVSA-N |
Search Google for chemicals with the same backbone | MUKCJOOKCZSQNW |
UniChem Compound Search for chemical match using the InChIKey | MUKCJOOKCZSQNW-DEOSSOPVSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | MUKCJOOKCZSQNW-DEOSSOPVSA-N |